LONG CYCLE-LIFE WOUND LITHIUM-ION BATTERY CELLS HAVING METALLIZED FILM CURRENT COLLECTORS

READY TO USE COMPOSITIONS OF CETRORELIX ACETATE

SUBCUTANEOUS FORMULATIONS OF ANTI-ABETA PROTOFIBRIL ANTIBODY AND METHODS OF USE THEREOF

METHODS OF PREVENTING METHIONINE OXIDATION IN IMMUNOCONJUGATES

METHODS OF TREATING OR PREVENTING STENT THROMBOSIS

Anhydrous Sodium Thiosulfate and Formulations Thereof

IL-2/IL-15RBETAGAMMA AGONIST COMBINATION WITH ANTIBODY-DRUG CONJUGATES FOR TREATING CANCER

COMPOSITIONS AND METHOD FOR TREATING ACUTE RADIATION SYNDROME

FUNCTIONAL OUTCOMES AFTER SPINAL CORD INJURY

A Method for the Production of a Product Used for Immune Modulation and Regeneration Purposes in Alopecia Areata, Androgenetic Alopecia, Scar, Neurodegenerative Inflammatory Diseases

BCMA chimeric antigen receptors and uses thereof

HYPERTONIC PHARMACEUTICAL COMPOSITIONS CONTAINING AN ANTI-PLATINUM CHEMOPROTECTANT AGENT

BETA-GLUCAN IN COMBINATION WITH ANTI-CANCER AGENTS AFFECTING THE TUMOR MICROENVIRONMENT

Regimens for treating HIV infections and aids

Systems and Methods for Treating an Opioid-Induced Adverse Pharmacodynamic Response

Stable nimodipine parenteral formulation

SUSTAINED-RELEASE MICROSPHERE COMPRISING DONEPEZIL

[6R]-MTHF IN B6 ENHANCED 5-FU BASED CHEMOTHERAPY OF PANCREATIC CANCER

METHODS OF ADMINISTERING IMMUNOSUPPRESSANTS HAVING A SPECIFIED PHARMACODYNAMIC EFFECTIVE LIFE AND THERAPEUTIC MACROMOLECULES FOR THE INDUCTION OF IMMUNE TOLERANCE

STABLE PHARMACEUTICAL COMPOSITIONS OF BENDAMUSTINE

METHODS OF TREATING CANCER

PHARMACEUTICAL FORMULATION AND A PROCESS FOR ITS PREPARATION

CALCIUM LACTATE COMPOSITIONS AND METHODS OF USE

CENTRAL NERVOUS SYSTEM MODULATORS AS COVID-19 THERAPEUTICS

VETERINARY USE AND DELIVERY OF AMMONIA OXIDIZING MICROORGANISMS

Products and Methods for Treatment of Amyotrophic Lateral Sclerosis

Compositions and Methods for Targeting Cancer Stem Cells

ANTI-PLASMA KALLIKREIN ANTIBODY DOSING REGIMENS FOR TREATING HEREDITARY ANGIOEDEMA

USE OF AN ANTI-TGFßR2/PD-1 BISPECIFIC ANTIBODY

GENE THERAPY FOR TUBEROUS SCLEROSIS

USE OF PROTON PUMP MODULATOR IN PREPARING REAGENT

Liver Specific Delivery of Messenger RNA

LEAKAGE INHIBITING AGENT FOR LOCAL INJECTION PREPARATION, LOCAL INJECTION PREPARATION INCLUDING THE SAME, AND METHOD FOR PRODUCING LOCAL INJECTION PREPARATION

TREATMENT OF CANCER PATIENTS WITH TUMOR INFILTRATING LYMPHOCYTE THERAPIES IN COMBINATION WITH KRAS INHIBITORS

Cellular Adjuvants for Viral Infection

INJECTION PARADIGM FOR ADMINISTRATION OF BOTULINUM TOXINS

FIBRINOGEN COMPOSITIONS AND METHODS OF PREPARATION

METHODS FOR PRODUCING STABLE THERAPEUTIC FORMULATIONS IN APROTIC POLAR SOLVENTS

CARDIOSPHERE-DERIVED CELLS AND THEIR EXTRACELLULAR VESICLES FOR TREATMENT AND PREVENTION OF CANCER

COMPOSITIONS AND METHODS FOR TREATMENT OF OBSTRUCTIVE SLEEP APNEA

mRNAS FOR TREATMENT OR PROPHYLAXIS OF LIVER DISEASES

METHOD OF PREVENTING OF SYSTEMIC-TO-PULMONARY-ARTERY SHUNT THROMBOSIS

Methods of Treating Retinal Vasculopathies

METHODS FOR REDUCING ISCHEMIA-REPERFUSION INJURIES

Methods For Treating Pancreatic Cancer Using Combination Therapies

APPLICATION OF ALKALOID COMPOUND HIP IN TREATMENT OF CARDIAC TRAUMA

IMMUNE MEMORY INDUCTION BY PLATINUM BASED COMPOUNDS

Methods and compositions for reducing symptoms of Parkinson's disease

MULTIPLE MYELOMA TREATMENT

TARGETED EXTRACELLULAR VESICLES COMPRISING MEMBRANE PROTEINS WITH ENGINEERED GLYCOSYLATION SITES

ANTI-PD-1 ANTIBODY PHARMACEUTICAL COMPOSITION AND USE THEREOF

DEVICES AND SYSTEMS FOR ABLATION THERAPY

METHODS OF USING ANTI-CD79B IMMUNOCONJUGATES TO TREAT DIFFUSE LARGE B-CELL LYMPHOMA

SULFATED POLYPEPTIDES FOR SYSTEMIC DELIVERY

HETEROTANDEM BICYCLIC PEPTIDE COMPLEX

TREATMENT OF A DISEASE OF THE GASTROINTESTINAL TRACT WITH AN IMMUNE MODULATORY AGENT RELEASED USING AN INGESTIBLE DEVICE

METHODS OF REDUCING PARTICLE FORMATION AND COMPOSITIONS FORMED THEREBY

READY-TO-USE PHARMACEUTICAL COMPOSITIONS OF POTASSIUM PHOSPHATES INJECTION

Phenoxy and benzyloxy substituted psychoplastogens and uses thereof

CELL CYCLE SYNCHRONIZATION PROCESS

PATEAMINE A DERIVATIVE FOR TREATING PANCREATIC CANCER

COMPOSITIONS AND METHODS FOR TREATING LIPOMA PAIN

FORMULATION AND METHOD FOR INCREASING ORAL BIOAVAILABILITY OF DRUGS

Lyophilized Vortioxetine Pamoate Powder for Injection and Preparation Method Therefor

STABLE PHARMACEUTICAL COMPOSITIONS OF APOMORPHINE

MODIFIED EASTERN EQUINE ENCEPHALITIS VIRUSES, SELF-REPLICATING RNA CONSTRUCTS, AND USES THEREOF

MODULATORS OF ENaC EXPRESSION

IL-1RA CDNAS

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS ASSOCIATED WITH HUMAN DISEASE

ADMINISTRATION OF NAKED NUCLEIC ACID MOLECULE

SUBCUTANEOUS UNIT DOSAGE FORMS

METHOD FOR INACTIVATING ZIKA VIRUS AND FOR DETERMINING THE COMPLETENESS OF INACTIVATION

PLACENTAL TISSUE PARTICULATE COMPOSITIONS AND METHODS OF USE

CAR VECTOR EXPRESSING IMMUNE REGULATORY FACTOR AND APPLICATION THEREOF

Olanzapine compositions and methods of use

ANTIBACTERIAL COMPOSITIONS

ROPIVACAINE SUSPENSION INJECTION, AND PREPARATION METHOD THEREFOR

METHOD OF ADMINISTRATION

MEMBRANE LIPID COATED NANOPARTICLES AND METHOD OF USE

Long Acting Injectable Formulation Comprising Risperidone And Biodegradable Polymers

METHOD AND COMPOSITIONS FOR THE TREATMENT AND DETECTION OF ENDOTHELIN-1 RELATED KIDNEY DISEASES

PH20 polypeptide variants, formulations and uses thereof

REGIMENS AND METHODS OF TREATING MULTIPLE SCLEROSIS USING OFATUMUMAB

HIGH CONCENTRATION ANTIBODY-CONTAINING LIQUID FORMULATION

Use of Anti-EGFR/Anti-Met Antibody to Treat Gastric or Esophageal Cancer

ANTIBODY AGAINST INHIBIN AND USE THEREOF

METHODS FOR PREVENTING CARDIAC OR SKELETAL DEFECTS IN DISEASES INCLUDING MUCOPOLYSACCHARIDOSES

NOVEL LIPID FORMULATIONS FOR DELIVERY OF THERAPEUTIC AGENTS

METHOD OF RECONSTITUTING LYOPHILIZED FORMULATION

SEMAGLUTIDE IN MEDICAL THERAPY

STABLE THERAPEUTIC COMPOSITIONS IN APROTIC POLAR SOLVENTS AND METHODS OF MANUFACTURING THE SAME

COMPOSITIONS OF EXENDIN-4 DERIVATIVES

THERAPEUTIC AGENTS AND/OR PHARMACEUTICAL COMPOSITIONS FOR NEUROCOGNITIVE DISORDERS

METHODS OF TREATING PROSTATE CANCER WITH GnRH ANTAGONIST

PLACENTAL MESENCHYMAL STEM CELLS, METHODS OF PRODUCTION, AND PLACENTAL MESENCHYMAL STEM CELL BASED THERAPEUTICS

BIOACTIVE RENAL CELLS FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE

INTRAVENOUS PHYSIOLOGICAL SOLUTION TO OPTIMIZE FLUID THERAPY IN PATIENTS

COMBINATIONS FOR THE TREATMENT OF NEUROLOGICAL CONDITIONS

Compositions And Methods For Inducing Apoptosis In Anaerobic Cells And Related Clinical Methods For Treating Cancer And Pathogenic Infections

METHODS, AGENTS, AND DEVICES FOR LOCAL NEUROMODULATION OF AUTONOMIC NERVES

PHARMACEUTICAL COMPOSITION

COMBINATION OF IMMUNOTHERAPEUTICS AND BISFLUOROALKYL-1,4-BENZODIAZEPINONE COMPOUNDS FOR TREATING CANCER

STABILIZATION OF PHENOBARBITAL SODIUM FOR INJECTION

CAPSID INHIBITORS FOR THE TREATMENT OF HIV

METHOD FOR TREATING DEMYELINATING CONDITIONS

TINOSTAMUSTINE FOR USE IN THE TREATMENT OF T-CELL PROLYMPHOCYTIC LEUKAEMIA

ORAL COMPOSITIONS COMPRISING KETAMINE COMBINED WITH SUBCUTANEAL OR INTRAVENOUS KETAMINE FOR USE IN THE TREATMENT, CONTROL OR PREVENTION OF DEPRESSIVE DISORDERS

SUSTAINED RELEASE CANCER THERAPEUTICS FORMULATIONS

ANIMAL MODEL FOR DISEASES ASSOCIATED WITH ABSENCE OR REDUCTION OF SOCIAL DOMINANCE, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DISEASES

ANTI-NPR1 ANTIBODIES AND USES THEREOF

Anti-Trkb Monoclonal Antibodies And Methods Of Use

ANTI-APOE ANTIBODIES

TGF- B receptor II isoform, fusion peptide, methods of treatment and methods in vitro

ANTI-oxMIF RADIOIMMUNOCONJUGATE

THERAPEUTIC GENE SILENCING WITH CRISPR-CAS13

SUBCUTANEOUSLY ADMINISTERED ANTIBODY-DRUG CONJUGATES FOR USE IN CANCER TREATMENT

ENHANCED TARGETING USING ANTIBODY-OLIGONUCLEOTIDE CONJUGATES

Pharmaceutical compositions having improved storage stability

COMPOSITIONS AND METHODS FOR THE PREVENTION AND/OR TREATMENT OF COVID-19

PERSONALIZED VACCINE ADMINISTRATION

AAV9-MEDIATED GENE THERAPY FOR TREATING MUCOPOLYSACCHARIDOSIS TYPE I

Combination Therapy for Treatment of Liver Disease

USE OF IL1-R1 DERIVED INHIBITOR OF IL-1B FOR THE TREATMENT OF IDIOPATHIC RECURRENT PERICARDITIS

METHODS FOR CONTROLLING BLEEDING IN A SUBJECT AFFLICTED WITH HERMANSKY PUDLAK SYNDROME USING PLATELET DERIVATIVE COMPOSITIONS

IMPROVED METHODS FOR THE USE OF PSYCHEDELICS

ANTIMICROBIAL COMPOSITIONS

GAS TRANSMISSION EMULSION FOR INTRAVENOUS ADMINISTRATION

METHODS AND COMPOSITIONS FOR TREATING A PROPROTEIN CONVERTASE SUBTILISIN KEXIN (PCSK9) GENE-ASSOCIATED DISORDER

COMPOUNDS AND METHODS FOR REDUCING TAU EXPRESSION

TREATMENT FOR HSV-1 USING A MEGANUCLEASE

IMPROVING ANTIBODY TOLERABILITY ASSOCIATED WITH INTRAVENOUS ADMINISTRATION

METHODS OF TREATING CANCER WITH ANTI-TIM-3 ANTIBODIES

NEUTRALIZING ANTIBODIES TO IL-17A, FUSION PROTEINS THEREOF, AND USES THEREOF

TREATMENT OF MAGE-A4 POSITIVE CANCER

1-METHYL-1H-PYRAZOL-3-YL DERIVATIVES FOR USE IN THE TREATMENT OF NEOVASCULAR DISEASES

PYRIDAZINONES FOR THE TREATMENT OR PREVENTION OF HYPERTENSION

METHOD FOR TREATING ACUTE MYELOID LEUKEMIA USING VENETOCLAX IN CONJUNCTION WITH LINTUZUMAB-AC225

VIRAL DELIVERY OF A SIALIDASE TO TREAT CANCER

OLIGONUCLEOTIDE CONJUGATES TARGETED TO THE TRANSFERRIN RECEPTOR

ANTI-FOLR1 IMMUNOCONJUGATES AND ANTI-PD-1 ANTIBODY COMBINATIONS

LIQUID DELIVERY COMPOSITION

RSV RNA VACCINES

Cellular Adjuvants for Viral Infection

NOVEL COMBINATIONS FOR ANTIGEN BASED THERAPY

NON-PROTEIN CLOSTRIDIAL TOXIN COMPOSITIONS

COMPOSITIONS AND METHODS FOR TREATING COLLAGEN-MEDIATED DISEASES

METHOD OF TREATING KNEE PAIN

ADDRESSING INJECTION SITE REACTIONS ASSOCIATED WITH THE ADMINISTRATION OF ELAMIPRETIDE

BACTERIOPHAGES FOR TREATMENT OF TUBERCULOSIS

AMMONIA OXIDIZING MICROORGANISMS FOR USE AND DELIVERY TO THE VISUAL AND AUDITORY SYSTEMS

METHOD FOR PREPARING INJECTABLE INJECTION COMPOSITION DERIVED FROM ANIMAL CARTILAGE, AND USE THEREOF

FORMULATIONS

COMPOSITIONS FOR TREATMENT OF DIABETIC SYMPTOMS

METHODS OF TREATING ACUTE RESPIRATORY DISTRESS SYNDROME WITH ACTIVATORS OF TIE-2

PHARMACEUTICAL COMPOSITION

METHODS AND COMPOSITIONS FOR TREATING CANCER

METHODS OF TREATING CENTRAL NERVOUS SYSTEM DISORDERS VIA ADMINISTRATION OF NANOPARTICLES OF AN MTOR INHIBITOR AND AN ALBUMIN

Safe and Effective Method of Treating Ulcerative Colitis with Anti-IL12/IL23 Antibody

ELP FUSION PROTEINS FOR CONTROLLED AND SUSTAINED RELEASE

REGENERATIVE POLYPEPTIDES AND USES THEREOF

BRAIN-TARGETED ANTIBODY NANOPARTICLE FOR NEURODEGENERATIVE DISEASES THERAPY

POLYMERIC PERFLUOROCARBON NANOEMULSIONS FOR ULTRASONIC DRUG UNCAGING

FACTOR IX SUBCUTANEOUS ADMINISTRATION WITH ENHANCED SAFETY

PHARMACEUTICAL COMPOSITIONS COMPRISING GLP-1R AGONISTS

RECOMBINANT POLYPEPTIDES AND COMBINATIONS FOR USE IN THE TREATMENT OF CANCER

PLACENTAL CELL TREATMENT FOR CRITICAL LIMB ISCHEMIA PATIENT SUBPOPULATIONS

Methods for Treating and/or Preventing Graft-Versus-Host Disease and/or Diffuse Alveolar Hemorrhage and/or Veno-Occlusive Disease Associated with Hematopoietic Stem Cell Transplant

TREATMENT REGIMENS

COMBINATION THERAPY EFFECTIVE AGAINST MICROORGANISMS, INCLUDING DRUG RESISTANT MICROORGANISMS

AQUEOUS, ROOM-TEMPERATURE STABLE ROCURONIUM COMPOSITION

PHARMACEUTICAL KIT FOR PARENTERAL CO-ADMINISTRATION

INTRAVENOUS ISTAROXIME FOR THE TREATMENT OF ACUTE HEART FAILURE

READY-TO-ADMINISTER HYDROMORPHONE FORMULATIONS

FORMULATIONS OF BENDAMUSTINE

Formulations of bendamustine

CARBON DIOXIDE-GENERATING NANOMATERIAL

Metal peroxide composite injectable hydrogel, preparation method and use thereof

SELECTION OF PATIENTS FOR COMBINATION THERAPY

AAV VECTOR VARIANTS FOR OCULAR GENE DELIVERY

COMPOSITION AND METHOD FOR TREATING HEMOPHILIA B

FORMULATIONS OF ANTI-PD1 ANTIBODIES

METHODS FOR TREATING SYSTEMIC SCLEROSIS

METHODS OF USE OF ANTI-IL-2 ANTIBODIES

Intratumoral Alpha-Emitter Radiation in Combination with Vasculature Inhibitors

COMPOSITION OF RADIOACTIVE AND NON-RADIOACTIVE MICROPARTICLES

TRUNCATED EVANS BLUE MODIFIED FIBROBLAST ACTIVATION PROTEIN INHIBITOR, PREPARATION METHOD AND APPLICATION THEREOF

STABLE EXPRESSION OF AAV VECTORS IN JUVENILE SUBJECTS

TARGETS FOR RNA THERAPEUTICS

TOBACCO MOSAIC VIRUS DELIVERY OF MITOXANTRONE FOR CANCER THERAPY

ANTICANCER DRUG-CONTAINING PLANT VIRUS PARTICLES

DOSING REGIMENS AND RELATED COMPOSITIONS AND METHODS

Liquid Protein Formulations Containing Ionic Liquids

GNE AS A THERAPEUTIC AGENT

COMPOSITIONS AND METHODS FOR THE TREATMENT OF GRAFT VERSUS HOST DISEASE

TARGETED PROTEIN DELIVERY TO MAMMALIAN EMBRYOS AND THERAPEUTIC APPLICATIONS USING EXOSOMES

DOSING REGIMENS

METHOD OF TREATING ALZHEIMER'S DISEASE

INJECTABLE ANTIBIOTIC FORMULATIONS AND USE THEREOF

LOW-SORBING GLYBURIDE FORMULATION AND METHODS

COMBINATION THERAPY FOR TREATING PIK3CA-MUTATED CANCER

COMPOSITIONS AND METHODS FOR INTRATHECAL ADMINISTRATION OF MCOPPB FOR PAIN RELIEF

METHODS OF TREATING ACUTE CORONARY SYNDROME USING 3,3'-DIINDOLYLMETHANE

RESCUE TREATMENT OF POST OPERATIVE NAUSEA AND VOMITING

COMPOSITIONS COMPRISING NITRIC OXIDE-RELEASING COMPOUNDS FOR TREATING CHOROIDAL VASCULAR DISEASES AND METHODS OF THEIR USE

METHODS FOR DECREASING INJURIES ASSOCIATED WITH INTRAOPERATIVE HYPOTENSION

SUBCUTANEOUS FORMULATION AND METHODS FOR TREATING EDEMA REFRACTORY TO ORAL DIURETICS

METHODS OF USING PROBENECID FOR TREATMENT OF CORONAVIRUS INFECTIONS

INTRAVENOUS DOFETILIDE TO CONVERT ATRIAL FIBRILLATION/FLUTTER

INTRAVENEOUS DOFETILIDE TO TERMINATE ARRHYTHMIC STORM FOLLOWING IMPLANTATION OF A CARDIAC DEFIBRILATOR

MRNA DELIVERY METHOD AND COMPOSITION THEREOF

NANOPARTICLE-MEDIATED ENHANCEMENT OF IMMUNOTHERAPY TO PROMOTE FERROPTOSIS-INDUCED CYTOTOXICITY AND ANTITUMOR IMMUNE RESPONSES

Biocompatible Protein-Based Particles and Methods Thereof

CRISPR/CAS9-BASED REPRESSORS FOR SILENCING GENE TARGETS IN VIVO AND METHODS OF USE

METHODS OF DOSING AND TREATMENT WITH A TACI-FC FUSION IMMUNOMODULATORY PROTEIN

COMPOUNDS, DEVICES, AND USES THEREOF

SYSTEM FOR TREATING A PATIENT

ASH1L INHIBITORS AND METHODS OF TREATMENT THEREWITH

SUPERCONCENTRATED FORMULATIONS OF BIOACTIVE AGENTS

Coronavirus vaccine

TREATMENT OF OBESITY AND OBESITY-RELATED DISORDERS

USE OF MULLERIAN INHIBITING SUBSTANCE (MIS) PROTEINS FOR CONTRACEPTION AND OVARIAN RESERVE PRESERVATION

ARMED CHIMERIC RECEPTORS AND METHODS OF USE THEREOF

NEW FORMULATIONS COMPRISING AZACITIDINE

17A-MONOESTERS AND 17A,21-DIESTERS OF CORTEXOLONE FOR USE IN THE TREATMENT OF TUMORS

FORMULATIONS FOR TREATMENT OF POST-TRAUMATIC STRESS DISORDER

VASOCONSTRICTION COMPOSITIONS AND METHODS OF USE

INJECTABLE FORMULATION

Methods and compositions for treating cancer

METHODS FOR TREATING NERVOUS SYSTEM DISORDERS WITH ANTIPURINERGIC AGENTS

NEW FORMULATIONS COMPRISING BIOLOGIC ACTIVE DRUGS

LONG-ACTING FORMULATIONS

COMPOSITIONS AND METHODS FOR THE INHIBITION OF NERVE GROWTH FACTOR AND THE TREATMENT/PREVENTION OF ATRIAL FIBRILLATION

DOSING FOR ANTI-TRYPTASE ANTIBODIES

COMPOSITIONS AND METHODS FOR INJECTING PARTICLE SUSPENSIONS

ANTIBODY BINDING CTLA-4 AND USE THEREOF

USE OF AN ANTI-CD19 ANTIBODY TO TREAT MYASTHENIA GRAVIS

Acute treatment and rapid treatment of headache using anti-CGRP antibodies

Method, facility and tank for the manufacture of a liquid acid concentrate used for hemodialysis machines

RECOMBINANT ADENO-ASSOCIATED VIRUSES FOR LESCH-NYHAN DISORDERS AND USES THEREOF

USE OF AMINO ACIDS AS STABILIZING COMPOUNDS IN PHARMACEUTICAL COMPOSITIONS CONTAINING HIGH CONCENTRATIONS OF PROTEIN-BASED THERAPEUTIC AGENTS

MULTIVALENT INFLUENZA VACCINES

METHODS OF TREATING ATOPIC DERMATITIS

POLYNUCLEOTIDES ENCODING METHYLMALONYL-COA MUTASE FOR THE TREATMENT OF METHYLMALONIC ACIDEMIA

METHODS FOR TREATING CERVICAL DYSTONIA

Pharmaceutical Composition for Treatment of Mucopolysaccharidosis Type 1

GENE THERAPY OF HEMOPHILIA A USING VIRAL VECTORS ENCODING RECOMBINANT FVIII VARIANTS WITH INCREASED EXPRESSION

PHARMACEUTICAL COMPOSITION AND KIT COMPRISING AN IMMUNOMODULATORY SUBSTANCE FOR TREATING DISEASES

METHODS FOR TREATMENT OF OSTEOARTHRITIS

STABLE READY TO DILUTE COMPOSITION OF CARFILZOMIB

COMPOSITIONS AND METHODS FOR ISLET CELL TRANSPLANTS

COMPOSITIONS AND METHODS OF CELLULAR IMMUNOTHERAPY

COMPOSITIONS AND METHODS FOR TREATING DISEASES AND DISORDERS OF THE CENTRAL NERVOUS SYSTEM

LEVOSIMENDAN FOR TREATING PULMONARY HYPERTENSION HEART FAILURE WITH PRESERVED EJECTION FRACTION (PH-HFpEF)

ARIPIPRAZOLE SUSTAINED-RELEASE MICROSPHERE AND PREPARATION METHOD THEREFOR

INJECTABLE MELATONIN COMPOSITION FOR THE TREATMENT OF VIRAL DISEASES

USE OF MITOXANTRONE HYDROCHLORIDE LIPOSOME IN PREPARATION OF DRUGS FOR TREATING ADVANCED SOLID TUMORS

MYRCENE-CONTAINING COMPLEX MIXTURES TARGETING TRPV1

SUBCUTANEOUS HER2 ANTIBODY FORMULATIONS

NUCLEIC ACID MOLECULE TARGETING MUTATION SITE OF CYP4V2 GENE AND USE THEREOF

Targeted Therapeutic Lysosomal Enzyme Fusion Proteins, Associated Formulations and Uses Thereof

METHODS OF TREATING DISEASES ASSOCIATED WITH ELEVATED URIC ACID

GPRC5D CHIMERIC ANTIGEN RECEPTORS AND CELLS EXPRESSING THE SAME

DOSING REGIMENS FOR PROTEIN THERAPEUTICS

ANTI-PNEUMOCOCCAL HYPERIMMUNE GLOBULIN FOR THE TREATMENT AND PREVENTION OF PNEUMOCOCCAL INFECTION

BINDING POLYPEPTIDES AGAINST SARS COV-2 AND USES THEREOF

POLYPEPTIDE FRAGMENTS, IMMUNOGENIC COMPOSITION AGAINST SARS-CoV-2, AND IMPLEMENTATIONS THEREOF

PRODUCTS AND METHODS FOR TREATING MUSCULAR DYSTROPHY

TOPIRAMATE COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME

METHODS OF TREATING LUNG CANCER WITH A PD-1 AXIS BINDING ANTAGONIST, A PLATINUM AGENT, AND A TOPOISOMERASE II INHIBITOR

METHODS OF TREATING ATOPIC DERMATITIS

Hyaluronidase Enzyme Formulations for High Volume Administration

METHODS FOR REGULATING FREE FATTY ACID FLUX USING FAT SPECIFIC PROTEIN 27 (FSP27) COMPOSITIONS

HIGHLY ACTIVE COMPOUNDS AGAINST COVID-19

KIT FOR PREVENTING OR TREATING FILOVIRUS AND FLAVIVIRUS DISEASES

INTERMITTENT DOSING OF MDM2 INHIBITOR

CONTROLLED RELEASE STERILE INJECTABLE ARIPIPRAZOLE FORMULATION AND METHOD

NEW FORMULATION FOR INJECTION COMPRISING 1-(5-(2,4-DIFLUOROPHENYL)-1-((3-FLUOROPHENYL)SULFONYL)-4-METHOXY-1H-PYRROL-3-YL)-N-METHYLMETHANAMINE

METHODS OF INTRAVENOUSLY ADMINISTERING SOTALOL

Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during PEGylated uricase therapy

ANTI -IL-23P19 ANTIBODY REGULATION OF GENES INVOLVED IN ULCERATIVE COLITIS

TREATMENT OF OCULAR DISEASES WITH FULLY-HUMAN POST-TRANSLATIONALLY MODIFIED ANTI-VEGF Fab

BRAIN TARGETING COMPOSITIONS AND METHODS OF USE THEREOF

ACTIVIN RECEPTOR TYPE IIB VARIANTS AND USES THEREOF

Azaindole rock inhibitors

GENE THERAPY CONSTRUCTS AND METHODS FOR TREATMENT OF HEARING LOSS

RECOMBINANT ADENO-ASSOCIATED VIRUS HAVING VARIANT CAPSID, AND APPLICATION THEREOF

ACIDIC NANOPARTICLES FOR RESTORATION OF AUTOPHAGY

ANTI-TISSUE FACTOR ANTIBODY-DRUG CONJUGATES AND THEIR USE IN THE TREATMENT OF CANCER

Adjuvant treatment of HER2-positive breast cancer

ENGINEERED CHIMERIC FUSION PROTEIN COMPOSITIONS AND METHODS OF USE THEREOF

METHODS OF TREATING TUMORS

IMMUNOGENIC COMPOSITIONS AND USES THEREOF

NON-PROTEIN CLOSTRIDIAL TOXIN COMPOSITIONS

NEUROTOXIN COMPOSITIONS FOR USE IN TREATING HEADACHE

COMPOSITIONS AND METHODS FOR PROMOTING THE MINERALIZATION OF BIOLOGICAL TISSUE

FORMATION OF BONE

Injectable Polymeric Biopharmaceutical Formulations

ADIPOSE COMPOSITIONS AND METHODS OF USE THEREOF

CANNABINOID RECEPTOR TYPE 2 (CB2) MODULATORS AND USES THEREOF

GASTRIC RESIDENCE SYSTEMS COMPRISING BUPRENORPHINE AND NALOXONE